Support Groups with Filters
Bri’s Journey to Living Life ‘By Design’
Discover how a brain tumor diagnosis led Bri to live a more fulfilling life and how she’s helping others do the same.
Connect with Your Community in 2024
A new year brings new opportunities to make a difference in the brain tumor community and empower yourself!
Clinical Trial Testing Effectiveness of Blood Cancer Drug in Recurrent Glioblastoma
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects Featured Clinical Study Study to Evaluate the Safety, Tolerability, and Optimal Dose
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)
Featured Clinical Study A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER) Study Sponsor: Boston Scientific Study website: Frontier Study
Cancer Support Community of Greater Ann Arbor Brain Tumor Support Group
Contact Person Taylor Fischman, LMSW 734-975-2500 Info@cancersupportannarbor.org Location Virtual Web Address Date and Time 2nd Thursday of every month 6:00 p.m. – 7:30 p.m. ET If you or a loved